Umbilical vessel oxytocin administration for retained placenta: in vitro study of various infusion techniques
Article Abstract:
Use of an infant mucus-aspiration catheter to inject the hormone oxytocin into the umbilical vein may be a simple and effective treatment for retained placenta. Retained placenta occurs when the placenta is not expelled following childbirth and can pose a serious threat to the mother. Five different techniques for administering oxytocin were compared. In four of the techniques, oxytocin was injected into the umbilical vein, and in the fifth, oxytocin was injected into an umbilical artery. In one of the techniques, a catheter was used, and a short cannula was used in the other four. Inserting a catheter into the cut end of the umbilical vein and injecting 30 milliliters of oxytocin was the most straightforward and effective technique. Furthermore, this technique can still be used when the umbilical cord is accessible but torn and when the umbilical vein has collapsed.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
Removing a retained placenta by oxytocin- A controlled study
Article Abstract:
After the delivery of an infant, the placenta is expelled as the last stage of labor. In seven cases where placental delivery was difficult, an injection of 100 units of oxytocin, the hormone responsible for uterine contractions and placental expulsion, was administered through the umbilical vein after fetal delivery. The effects of this dose of oxytocin were then evaluated. Delivery of the placenta was expedited, taking 12 minutes after oxytocin injection, compared with 40 minutes in women given a placebo. At no time did the level of oxytocin in the mother's blood increase. The procedure and drug use are considered safe and highly effective.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1989
User Contributions:
Comment about this article or add new information about this topic:
Sulprostone reduces the need for the manual removal of the placenta in patients with retained placenta: A randomized controlled trial
Article Abstract:
A study to determine the extent that the administration of sulporstone reduces the need for manual removal of the placenta in patients with retained placentas was conducted. The results revealed that the sulporstone reduced the need for manual removal of the placenta by 49%.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Activation of coagulation after administration of tumor necrosis factor to normal subjects. Redesigning heparin
- Abstracts: Glucose tolerance in pregnancy: ethnic variation and influence of body habitus. Race as a predictor of urinary incontinence and pelvic organ prolapse
- Abstracts: Amplification dynamics: predicting the effect of HIV on tuberculosis outbreaks. RNAi: Towards in vivo therapy
- Abstracts: The twin-twin transfusion syndrome. "Macrosomic" twinning: a study of growth-promoted twins. Second-breech presentation in twins - a possible adaptive measure to promote fetal growth
- Abstracts: Human atrial natriuretic factor and renin-aldosterone in paracetamol induced fulminant hepatic failure. Immune mechanisms in tienilic acid associated hepatotoxicity